Figure 2.
Figure 2. Distribution of CNS-specific CD4+ and CD8+ T-cell responses. CFSE-based proliferation assays were performed on PBMC specimens from 8 healthy individuals and 43 untreated patients with MS (RRMS, n = 17; PPMS, n = 20; SPMS, n = 6). Each subject was tested against 15 distinct pools of CNS peptides, representing 9 distinct CNS target proteins. The y-axis demonstrates the mean number of peptide pools (+ 2 SEM) against which a positive response was observed in the indicated subject groups. Black bars (▪) indicate CD4+ T-cell responses, whereas gray bars () represent CD8+ responses. The ranges are indicated in parentheses. *CD4+ responses to a significantly higher array of peptide pools were observed compared with CD8+ responses (P < .05).

Distribution of CNS-specific CD4+ and CD8+ T-cell responses. CFSE-based proliferation assays were performed on PBMC specimens from 8 healthy individuals and 43 untreated patients with MS (RRMS, n = 17; PPMS, n = 20; SPMS, n = 6). Each subject was tested against 15 distinct pools of CNS peptides, representing 9 distinct CNS target proteins. The y-axis demonstrates the mean number of peptide pools (+ 2 SEM) against which a positive response was observed in the indicated subject groups. Black bars (▪) indicate CD4+ T-cell responses, whereas gray bars () represent CD8+ responses. The ranges are indicated in parentheses. *CD4+ responses to a significantly higher array of peptide pools were observed compared with CD8+ responses (P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal